cromolyn sodium has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corwin, MA; Samoszuk, M | 1 |
| Auerbach, R; Kubai, L; Morrissey, LW; Sidky, YA | 1 |
2 other study(ies) available for cromolyn sodium and Adenocarcinoma
| Article | Year |
|---|---|
Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer.
Topics: Adenocarcinoma; Animals; Anti-Asthmatic Agents; Blood Coagulation; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Case-Control Studies; Cell Hypoxia; Cromolyn Sodium; Female; Humans; Mammary Neoplasms, Experimental; Mast Cells; Mice; Mice, Inbred BALB C; Neoplasm Staging; Serine Endopeptidases; Thrombosis; Tryptases | 2003 |
Regional differences in tumor growth: studies of the vascular system.
Topics: Adenocarcinoma; Animals; Capillaries; Cromolyn Sodium; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Microcirculation; Microspheres; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Skin; Skin Temperature; Transplantation, Homologous | 1978 |